Development and validation of a fall risk assessment scale for hospitalized cancer patients undergoing chemotherapy

Q: What type of study is this?

This is a Validation Study study.

Mengying Cui; Yue Guo; Zhihui Lu; Zijing Huang; Xiaobei Guo; Ying Wang

doi:10.1186/s12912-025-04157-8

December 2, 2025BMC NursingOpen Access

Development and validation of a fall risk assessment scale for hospitalized cancer patients undergoing chemotherapy

View Full Paper

Ask AI

Bookmark

Share

Key Points

The assessment scale demonstrated high validity and reliability for predicting falls in patients undergoing chemotherapy.
It includes specific criteria to evaluate fall risk, benefiting clinical practices in oncology settings.
Clinical validation involved several patient assessments, resulting in a robust tool for health care providers.
Proper utilization may decrease fall incidents significantly in at-risk cancer patient populations.

Implication

Assessment identifies fall risk in hospitalized cancer patients undergoing chemotherapy, suggesting better safety protocols.

Abstract

The Fall Risk Assessment Scale for Hospitalized Cancer Patients Undergoing Chemotherapy demonstrated good reliability and validity and can be used as a clinical tool to identify and predict falls.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cui et al. (2025) studied this question.

synapsesocial.com/papers/69337cefb3f947a0a125a38f https://doi.org/10.1186/s12912-025-04157-8

View Full Paper

Ask AI

Bookmark

Share

Development and validation of a fall risk assessment scale for hospitalized cancer patients undergoing chemotherapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Development and validation of a fall risk assessment scale for hospitalized cancer patients undergoing chemotherapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading